The Coalition for Cancer
The Asia Society Policy Institute (ASPI) and the Memorial Sloan Kettering Cancer Center (MSK) have been working together since 2017 to enhance collaboration between the U.S., China, and the rest of the world in tackling the common enemy of cancer. This collaborative effort aims to accelerate the eradication of cancer as a major cause of death (or a cure for cancer) in a lifetime, through multi-stakeholder, multi-regional collaboration on patient-centric clinical trials and international regulatory harmonization.
Continuing the collaboration between ASPI and MSK, the Bloomberg New Economy International Cancer Coalition (the “Coalition”) was launched in 2021 at the Bloomberg New Economy Forum in Singapore. The Coalition brings together public-private sector leading representatives from academia, government regulatory agencies, the pharmaceutical and biotechnology industry, and patient advocacy groups across North America, Europe, and Asia. These global representatives advocate for strengthening international clinical trial collaboration in order to accelerate the development, access, and approval of cancer treatments and prevention that could save millions of lives. In the process, the Coalition also demonstrates the potential lifesaving results that can be the outcome of cooperation among experts in the United States, China, Europe, and beyond.
Partners and Supporters
- Memorial Sloan Kettering Cancer Center (MSK)
- Chinese Thoracic Oncology Group (CTONG)
- Bloomberg New Economy Forum
- Forbes China
- Thoracic Oncology Group of Australasia (TOGA)
- Asia Society Policy Institute
The Honorable Dr. Kevin Rudd
Former President & CEO, Asia Society; President Emeritus, Asia Society Policy Institute; Founding Chair, Center for China Analysis
Dr. Bob Li
Medical Oncologist and Physician Ambassador to China and Asia-Pacific, Memorial Sloan Kettering Cancer Center; Senior Fellow on Global Public Health, Center for China Analysis at the Asia Society Policy Institute.
Co-Founder and Managing Director, Center for China Analysis at the Asia Society Policy Institute
Senior Fellow on Global Public Health, Center for China Analysis at the Asia Society Policy Institute
Director of Operations, Asia Society Policy Institute; Project Manager, Center for China Analysis
Junior Fellow on Global Public Health, Center for China Analysis at the Asia Society Policy Institute
Funding and Support
The Cure4Cancer International Clinical Trials Collaboration (C4C) public awareness initiative at Asia Society is supported by an unrestricted education grant from AstraZeneca.
We would welcome other industry and philanthropic support for this non-profit international movement to accelerate the Cure4Cancer.